Publication: 253

Publication: 253

Ki67 and PIM1 expression predict outcome in mantle cell lymphoma treated with high dose therapy, stem cell transplantation and rituximab: a Cancer and Leukemia Group B 59909 correlative science study

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: Leuk Lymphoma vol 49 (11) 2081-2090

Year:: 2008
Type:: Manuscript
Funding:: NCTN
Endpoint:: Secondary-not-in-original
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pmc-release

Note:

Methodological:: No
Biospecimen:: Yes
SDC:: No
Book Volume:

Parents:: 735
Children:: None

Program:: OGC
Primary Committee:: Lymphoma
Sec. Committees:

Pharmas:
Grants:: N01 CA004919, U10 CA032291, CA33601, CA58348, CA77597, CA04457, CA11789, U10 CA077658, U10 CA004919, CA77406, CA35113, CA32291, CA41287, U10 CA035279, CA03927, U10 CA031946, U10 CA033601, CA60138, U10 CA077597, CA35279, U10 CA077440, CA77440, U10 CA105409, U10 CA041287, U10 CA035113, U10 CA047559, CA105409, CA04326, CA21060, CA47559, CA77658, CA016254, CA31946, U10 CA003927, CA07968

Corr. Author:
Authors:: Eric D. Hsi Sin-Ho Jung Raymond Lai Jeffrey L. Johnson James R. Cook Dan Jones Sven Devos Bruce D. Cheson Lloyd E. Damon Jonathan Said

Networks:

Study: CALGB-59909
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 2

Keywords:: Mantle cell lymphoma, prognosis, Ki67, PIM1, clinical trial, transplant